Replimune Group, Inc.
Total Trades
46
Buys
0
Sells
39
Largest Trade
$1M+
Insiders
13
Institutional Funds
120
Inst. Value
$1M+
Activist Filings
37
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dhingra Kapil | Director | SELL | $15K–$50K | 3K | $10.40 | Dec 11, 2025 |
| Dhingra Kapil | Director | EXERCISE | $1K–$15K | 3K | $1.75 | Dec 11, 2025 |
| Patel Sushil | CEO | SELL | $100K–$500K | 10K | $11.13 | Dec 4, 2025 |
| Sarchi Christopher | Chief Commercial O… | SELL | $15K–$50K | 5K | $9.10 | Nov 19, 2025 |
| Xynos Konstantinos | Chief Medical Offi… | SELL | $50K–$100K | 7K | $9.10 | Nov 19, 2025 |
| Astley-Sparke Philip | Director | SELL | $100K–$500K | 32K | $8.06 | May 23, 2025 |
| Xynos Konstantinos | Chief Medical Offi… | SELL | $50K–$100K | 8K | $8.06 | May 23, 2025 |
| Schwendenman Andrew | Chief Accounting O… | SELL | $15K–$50K | 3K | $8.05 | May 23, 2025 |
| Patel Sushil | CEO | SELL | $100K–$500K | 25K | $8.06 | May 23, 2025 |
| Hill Emily Luisa | CFO | SELL | $15K–$50K | 3K | $8.05 | May 23, 2025 |
| Sarchi Christopher | Chief Commercial O… | SELL | $15K–$50K | 4K | $8.05 | May 23, 2025 |
| Xynos Konstantinos | Chief Medical Offi… | SELL | $50K–$100K | 7K | $10.78 | Nov 21, 2024 |
| Sarchi Christopher | Chief Commercial O… | SELL | $50K–$100K | 5K | $10.78 | Nov 21, 2024 |
| Hill Emily Luisa | CFO | SELL | $50K–$100K | 9K | $10.18 | Aug 20, 2024 |
| Xynos Konstantinos | Chief Medical Offi… | SELL | $100K–$500K | 16K | $7.50 | Jun 11, 2024 |
| Xynos Konstantinos | Chief Medical Offi… | SELL | $50K–$100K | 7K | $10.92 | Nov 18, 2023 |
| Sarchi Christopher | Chief Commercial O… | SELL | $50K–$100K | 5K | $10.92 | Nov 18, 2023 |
| Esposito Pamela | Chief Business Off… | SELL | $100K–$500K | 6K | $20.01 | Sep 14, 2023 |
| Esposito Pamela | Chief Business Off… | EXERCISE | $15K–$50K | 6K | $3.30 | Sep 14, 2023 |
| Esposito Pamela | Chief Business Off… | EXERCISE | $100K–$500K | 19K | $6.58 | Aug 25, 2023 |
| Esposito Pamela | Chief Business Off… | SELL | $100K–$500K | 19K | $20.01 | Aug 25, 2023 |
| Esposito Pamela | Chief Business Off… | SELL | $15K–$50K | 1K | $20.00 | Aug 16, 2023 |
| Esposito Pamela | Chief Business Off… | EXERCISE | $1K–$15K | 1K | $3.30 | Aug 16, 2023 |
| Esposito Pamela | Chief Business Off… | SELL | $100K–$500K | 20K | $21.58 | Jul 12, 2023 |
| Esposito Pamela | Chief Business Off… | EXERCISE | $100K–$500K | 20K | $6.35 | Jul 12, 2023 |
| Lewis Tanya | Chief Dev. Op. Off… | SELL | $100K–$500K | 13K | $24.06 | Jun 16, 2023 |
| Patel Sushil | Chief Strategy Off… | SELL | $100K–$500K | 6K | $24.05 | Jun 16, 2023 |
| Patel Sushil | Chief Strategy Off… | SELL | $100K–$500K | 16K | $18.05 | May 19, 2023 |
| Coffin Robert | President & Chief … | SELL | $100K–$500K | 8K | $18.05 | May 19, 2023 |
| Lewis Tanya | Chief Dev. Op. Off… | SELL | $100K–$500K | 12K | $18.05 | May 19, 2023 |
| Love Colin | COO | SELL | $100K–$500K | 11K | $18.05 | May 19, 2023 |
| Franchi Jean M. | CFO | SELL | $100K–$500K | 11K | $18.05 | May 19, 2023 |
| Xynos Konstantinos | Chief Medical Offi… | SELL | $1K–$15K | 771 | $18.05 | May 19, 2023 |
| Esposito Pamela | Chief Business Off… | SELL | $100K–$500K | 6K | $18.05 | May 19, 2023 |
| Astley-Sparke Philip | CEO | SELL | $100K–$500K | 18K | $18.05 | May 19, 2023 |
| Esposito Pamela | Chief Business Off… | SELL | $100K–$500K | 15K | $25.03 | Dec 14, 2022 |
| Esposito Pamela | Chief Business Off… | EXERCISE | $15K–$50K | 15K | $1.01 | Dec 14, 2022 |
| Love Colin | COO | SELL | $50K–$100K | 6K | $14.59 | May 18, 2022 |
| Esposito Pamela | Chief Business Off… | SELL | $50K–$100K | 4K | $14.59 | May 18, 2022 |
| Franchi Jean M. | CFO | SELL | $50K–$100K | 3K | $14.59 | May 18, 2022 |
| Lewis Tanya | Chief Dev. Op Offi… | SELL | $50K–$100K | 5K | $14.59 | May 18, 2022 |
| Patel Sushil | Chief Commercial O… | SELL | $100K–$500K | 11K | $14.59 | May 18, 2022 |
| Coffin Robert | President & Chief … | SELL | $50K–$100K | 6K | $14.59 | May 18, 2022 |
| Astley-Sparke Philip | CEO | SELL | $100K–$500K | 10K | $14.59 | May 18, 2022 |
| Omega Fund IV, L.P. | 10% Owner | EXERCISE | $100K–$500K | 17K | $9.78 | Mar 17, 2022 |
| Omega Fund IV, L.P. | 10% Owner | SELL | $1M+ | 107K | $15.55 | Mar 17, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 120 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 3.7M | $1M+ | SH |
| VANGUARD GROUP INC | 3.3M | $1M+ | SH |
| TORONTO DOMINION BANK | 2.2M | $1M+ | SH |
| Erste Asset Management GmbH | 2.1M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $1M+ | SH |
| Rosalind Advisors, Inc. | 1.4M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 1.2M | $1M+ | SH |
| ADAR1 Capital Management, LLC | 1.2M | $1M+ | SH |
| Ally Bridge Group (NY) LLC | 1.2M | $1M+ | SH (Call) |
| Redmile Group, LLC | 1.1M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.0M | $1M+ | SH |
| Jefferies Financial Group Inc. | 714K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 588K | $1M+ | SH |
| NAN FUNG TRINITY (HK) Ltd | 576K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 461K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 405K | $1M+ | SH |
| Quinn Opportunity Partners LLC | 393K | $1M+ | SH |
| BARCLAYS PLC | 292K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 266K | $1M+ | SH |
| HRT FINANCIAL LP | 184K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2025
0.7%
536K shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 14, 2025
4.7%
3.6M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Nov 14, 2025
10.6%
8.3M shares
SC 13G · Nov 14, 2025
8.2%
6.4M shares
Point72 Asset Management, L.P.
SC 13G · Jul 31, 2025
5.7%
4.5M shares
SC 13G/A · May 16, 2025
6.4%
4.9M shares
SC 13D · Mar 7, 2025
14.3%
11.0M shares
Forbion Capital Fund III Cooperatief U.A.
SC 13G/A · Feb 14, 2025
6.1%
4.2M shares
SC 13G/A · Jan 31, 2025
4.8%
3.6M shares
SC 13G/A · Nov 14, 2024
16.2%
11.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
14.5%
9.9M shares
SC 13G/A · Nov 14, 2024
4.0%
2.7M shares
Forbion Capital Fund III Coöperatief U.A.
SC 13G/A · Nov 14, 2024
7.5%
5.1M shares
SC 13G/A · Nov 12, 2024
5.1%
3.5M shares
SC 13G/A · Nov 4, 2024
5.1%
3.5M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G/A · Oct 7, 2024
2.3%
1.5M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jul 10, 2024
1.7%
0 shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Apr 10, 2024
10.7%
6.5M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Apr 10, 2024
10.6%
0 shares
SC 13G/A · Feb 14, 2024
5.5%
3.2M shares
SC 13G/A · Feb 14, 2024
7.4%
4.6M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
9.9%
5.9M shares
Forbion Capital Fund III Coöperatief U.A.
SC 13G/A · Feb 14, 2024
8.7%
5.2M shares
SC 13G/A · Jan 26, 2024
7.7%
4.5M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Jan 25, 2024
8.7%
0 shares
SC 13G/A · Jan 10, 2024
16.2%
9.5M shares
SC 13G/A · Feb 14, 2023
9.9%
5.7M shares
SC 13G · Feb 14, 2023
10.0%
5.8M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
9.2%
5.1M shares
SC 13G/A · Feb 13, 2023
7.2%
3.6M shares
SC 13G · Feb 3, 2023
5.5%
3.0M shares
SC 13D/A · Dec 6, 2022
3.0%
1.5M shares
SC 13G/A · Nov 18, 2022
9.9%
5.2M shares
SC 13D/A · Sep 14, 2022
4.4%
2.2M shares
SC 13G/A · Feb 14, 2022
9.9%
4.8M shares
SC 13G/A · Feb 14, 2022
10.6%
5.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
12.5%
5.9M shares